Pierre Massion

Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign. Read More

A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors. Read More

New research by Jonathan Lehman and Pierre Massion have identfied a bioimarker that suggests poor prognosis for small-cell lung cancer, as well as potential target for new therapies. Read More

Xiangming Ji, Pierre Massion and colleagues have discovered that blocking the transporter protein xCT could slow the progression of non-small cell lung cancer. Read More

The 3rd National Veterans Health Affairs Research Conference held at Vanderbilt University Medical Center May 17-18. Read More

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. Read More

Vanderbilt researchers have received an R01 grant from the National Institutes of Health to study a novel non-invasive imaging approach to detect activation of inflammatory cells in the lungs of patients with chronic obstructive pulmonary disease (COPD), a progressive lung condition that makes breathing difficult. Read More

Pierre Massion, M.D., Cornelius Vanderbilt Professor of Medicine, has been named to direct the Vanderbilt-Ingram Cancer Center (VICC) Cancer Early Detection and Prevention Initiative. Read More

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies. Read More

Pierre Massion, M.D., director of the Thoracic Program and an Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has been recognized for his pioneering work in lung cancer by the LUNGevity Foundation. Read More

Seven faculty members of the Vanderbilt University School of Medicine named to endowed chairs were honored for their academic achievements during a celebration on Wednesday at the Student Life Center. Read More

Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer. Read More

For years, scientists have known that regular aspirin use may reduce the risk of cancer. Read More

Barbara Forbes loves a quitter. Read More

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor. Read More

Smokers who want assistance to help them kick the habit are invited to a free counseling session with a “quit-smoking” adviser, Tuesday, Feb. 26, 5:30-7:30 p.m. at Vanderbilt Health One Hundred Oaks, first floor conference room. Read More

Laura Beth Brown, R.N., president of Vanderbilt Home Care, was named vice president for Vanderbilt Health Services. While continuing to serve as president for Vanderbilt Home Care, Brown will provide operational oversight for Vanderbilt Health Services (VHS) and its subsidiary entities. Michelle Collins, Ph.D., CNM, was… Read More

Pierre Massion, M.D., associate professor of Medicine and Cancer Biology, has been named director of the Thoracic Program at Vanderbilt-Ingram Cancer Center. Read More

More Tennesseans are expected to die this year from lung cancer than any other form of cancer, yet lung cancer research receives far less funding than other forms of the disease. Read More